Reduction of proteinuria with angiotensin receptor blockers.
about
Dopamine D1 receptor (DRD1) genetic polymorphism: pleiotropic effects on heritable renal traitsImpaired endocytosis in proximal tubule from subchronic exposure to cadmium involves angiotensin II type 1 and cubilin receptors.Clinical features and outcomes of 98 children and adults with dense deposit disease.Proteinuria, but Not eGFR, Predicts Stroke Risk in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort Study.Proteinuria in dogs and catsProgress in pathogenesis of proteinuria.Sirtuins and renal diseases: relationship with aging and diabetic nephropathy.Impact of AT2 receptor deficiency on postnatal cardiovascular development.The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney diseaseAddition of aliskiren to Angiotensin receptor blocker improves ambulatory blood pressure profile and cardiorenal function better than addition of benazepril in chronic kidney disease.Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study.Losartan chemistry and its effects via AT1 mechanisms in the kidneyProteomic urinary biomarker approach in renal disease: from discovery to implementation.Low-protein diet supplemented with ketoacids ameliorates proteinuria in 3/4 nephrectomised rats by directly inhibiting the intrarenal renin-angiotensin system.Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways.Two-Year Changes in Proteinuria and the Risk of Stroke in the Chinese Population: A Prospective Cohort Study.Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis.Influence of Olmesartan on Sirtuin 1 mRNA Expression in 5/6 Nephrectomized Spontaneously Hypertensive Rats.The ZDSD rat: a novel model of diabetic nephropathy.Is the reno-protective effect of valsartan dose dependent? A comparative study of 80 and 160 mg day(-1).Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy.Basic fibroblast growth factor reduces functional and structural damage in chronic kidney disease.Angiotensin II induces reorganization of the actin cytoskeleton and myosin light-chain phosphorylation in podocytes through rho/ROCK-signaling pathway.
P2860
Q33577233-892CE2A1-A7B7-4737-BEC7-90A90C178C79Q35007884-56C623E0-0A36-4FE6-934A-349FA341DC52Q35580577-1C28C03F-38CD-4DE6-8B2A-B394DAC5AFADQ35901161-84059135-F6E3-42B9-90D8-0F20564513F5Q35967679-BD44E939-8746-4AFA-B1DC-B5C0618D11A3Q36011008-892B9710-D35E-4A82-BEEB-BE8DB28C27C9Q36304756-89D8071E-8B2F-4A7A-BA5A-465E9D5F005AQ36354009-9C4C9A39-646D-46D1-A002-02067A678E54Q36675029-A6995182-D0E5-4642-955D-1215233C242EQ37139028-F76DD288-A2A8-4235-93C7-7C03213EB3DCQ37167598-D2B8EE5A-EAA4-4A80-8922-B3DFAC22DF67Q37595616-2DACAF04-2BC1-485E-81B4-25631B471C0BQ38196316-ACF91254-4756-4747-9233-3EBBBB2D55CEQ38740309-18C9B442-E419-4EBB-A102-331B7049AE54Q40053242-2FED34EE-DB52-40B1-B7AA-B01BEEBA3EFBQ40139081-72CA2005-A5AD-4B4C-B44E-CD0760086376Q41652967-64F1B3B5-721B-46BA-80B5-5745C1FA57F9Q41841764-8745BB19-F5BD-438C-AD68-BA9BE54E743BQ41965910-E21C423C-EA4E-418F-98CD-E123283DE477Q43016390-3283C723-5608-40DA-93E7-63682526A904Q43284478-5FDADAC8-5D47-4C29-9978-ACA8FA0D26C5Q44507544-1CADC5CB-7B0C-4BD7-8F71-7292CA04312EQ52896749-81F0EEF8-6D5E-4E09-A38E-CB5F784DF471
P2860
Reduction of proteinuria with angiotensin receptor blockers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reduction of proteinuria with angiotensin receptor blockers.
@en
Reduction of proteinuria with angiotensin receptor blockers.
@nl
type
label
Reduction of proteinuria with angiotensin receptor blockers.
@en
Reduction of proteinuria with angiotensin receptor blockers.
@nl
prefLabel
Reduction of proteinuria with angiotensin receptor blockers.
@en
Reduction of proteinuria with angiotensin receptor blockers.
@nl
P2860
P356
P1476
Reduction of proteinuria with angiotensin receptor blockers.
@en
P2093
P2860
P304
P356
10.1038/NCPCARDIO0806
P478
P577
2008-07-01T00:00:00Z